SAHPRA INVOLVEMENT IN THE SWISSMEDIC MARKETING AUTHORISATION FOR GLOBAL HEALTH PRODUCTS (MAGHP) PROCEDURE

The Marketing Authorisation for Global Health Products (hereinafter referred to as MAGHP) procedure is a Swissmedic project in the area of regulatory systems strengthening. The aim of the MAGHP project by Swissmedic is to increase the efficiency of the regulatory review and registration process by focusing stakeholders on value-added activities, and to strengthen the regulatory authorities’ ability to protect their citizens’ health (capacity building).